×
Hero Background

Genitourinary Drugs Companies

ID: MRFR/Pharma/5338-HCR
85 Pages
Rahul Gotadki
October 2025

Genitourinary Drugs companies focus on advancing therapies for urinary and reproductive health. Through dedicated research, development, and distribution, these organizations provide innovative medications, contributing to improved outcomes for individuals dealing with genitourinary disorders.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Genitourinary Drugs Market Research Report - Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Genitourinary Drugs Market

Genitourinary Drugs Market

 


Latest Genitourinary Drugs Companies Updates:


Pfizer's Xtandi Approval: Pfizer secured FDA approval for Xtandi's expanded use in treating prostate cancer, potentially boosting their market share.


Johnson & Johnson's Spravato Expansion: J&J received FDA approval for Spravato (esketamine) as a maintenance treatment for depression, potentially opening up new avenues for the drug.


AstraZeneca's Lynparza Milestone: AstraZeneca announced Lynparza achieved blockbuster status, generating over $1 billion in annual sales for ovarian cancer treatment.


List of Genitourinary Drugs companies in the market:



  • Abbott

  • Astellas Pharma Inc.

  • AstraZeneca

  • Pfizer Inc.

  • Eli Lilly and Company

  • Genentech, Inc.

  • Immunex Corp.

  • GlaxoSmithKline plc.

  • Ionis Pharmaceuticals

  • Merck & Co., Inc.

  • Novartis AG